Chiral phenoxyacetic acid analogues inhibit colon cancer cell proliferation acting as PPARγ partial agonists

Lina Sabatino(University of Sannio), Antonio Lavecchia(University of Naples Federico II)

Scientific Reports

April 1, 2019

10.1038/s41598-019-41765-2

Cited by 24

Related Papers

Modeling of κ-Opioid Receptor/Agonists Interactions Using Pharmacophore-Based and Docking Simulations

|Journal of Medicinal Chemistry|2000|51

3-Aryl[1,2,4]triazino[4,3-<i>a</i>]benzimidazol-4(10<i>H</i>)-ones: A New Class of Selective A<sub>1</sub> Adenosine Receptor Antagonists

|Journal of Medicinal Chemistry|2001|48

2-(Benzimidazol-2-yl)quinoxalines: A Novel Class of Selective Antagonists at Human A<sub>1</sub>and A<sub>3</sub>Adenosine Receptors Designed by 3D Database Searching

|Journal of Medicinal Chemistry|2005|48

Quercetin’s Dual Mode of Action to Counteract the Sp1-miR-27a Axis in Colorectal Cancer Cells

|Antioxidants|2023|15